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ABSTRACT
Characterized by social impairments, repetitive or compulsive behaviors, and
speech deficits, the underlying causes of Autism Spectrum Disorder (ASD) are
currently unknown. Both oxytocin and arginine vasopressin are involved in
regulating social behaviors in mammals and the dysregulation of each is thought
to play a role in social impairments associated with ASD. Studying the secretion
dynamics of these peptides can help us better understand regulatory
relationships that may be involved in neurodevelopmental disorders like ASD.
Microfluidic brain slice culture is an important tool for ex vivo modeling of basal
and diseased state neurochemistry. A significant challenge to culturing brain
slices in microfluidic flow systems is the efficient delivery of oxygen to enable
medium to long-term viability of tissue slice. A microfluidic slice culture device
that delivers continuous flow of carbogen gas-segmented culture media droplets
to an immobilized brain tissue slice for total perfusion, enabling efficient
oxygenation has been developed. The size of tissue slices, and the dimensions
of the required tissue chamber present a lower limit of droplet volume on the
order of 10 μL, which is a relatively large volume compared to many microfluidic
systems. For downstream assay of cellular secretions, sample preconcentration
is needed. An electrophoretic platform for sample preconcentration within the
gas-segmented perfusate droplets has been developed.
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CHAPTER 1. INTRODUCTION
1.1 Autism Spectrum Disorder
Autism Spectrum Disorder (ASD) is a developmental disorder characterized by
abnormal social interaction, repetitive or compulsive behaviors, speech deficits,
and restricted interest.1,2 Presentation of autistic features varies and can range
from mild to severe.3 Individuals also show varying cognitive development,
ranging from those who function well above average to those who show
intellectual disabilities.3 The Centers for Disease Control and Prevention has
been tracking the prevalence of ASD since 1996 through the Autism and
Developmental Disabilities Monitoring (ADDM) Network. In 2016, the combined
ASD prevalence, with data from all ADDM sites, was one in 54 children aged 8
years.4 While ASD is a disorder with strong genetic correlations, no single
genetic mutation accounts for more than 1-2% of ASD cases.2,5 Assessment of
chromosomal variations, as well as other gene related studies have shown a
wide range in genes with predisposing mutations and polymorphisms associated
with ASD.2 Neuroanatomical studies, one of the various approaches used to
study the underlying mechanisms of ASD, have reported abnormal neuronal
connectivity in autistic individuals.2 While the scientific community struggles to
identify the key neurophysiological mechanisms of ASD, the neuroendocrine
mechanisms involved are relatively less studied.
1.1.1 Neuropeptides of ASD
Oxytocin and arginine vasopressin. Oxytocin (OT) is a hormone that is
synthesized by the magnocellular neurons of the supraoptic (SON) and
paraventricular (PVN) nuclei within the hypothalamus.6,7 OT helps induce the
production of milk and facilitate uterine contractions during childbirth.7 Arginine
vasopressin (AVP) is a peptide, also synthesized in both the SON and PVN, that
regulates the tonicity of body fluids by increasing the amount of solute-free water
reabsorbed by the kidneys, which is then returned to the vascular system.8 In
addition to being produced in the same nuclei of the hypothalamus, OT and AVP
are also similar in structure. Both neuropeptide structures consist of a six amino
acid ring with a three amino acid tail, and only differ by two amino acids, in the
third and eighth positions (Figure 1-1).9–11 These neuropeptides are released into
the bloodstream from axon terminals in the posterior pituitary.12
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Figure 1-1. Neuropeptides of ASD. Diagram of oxytocin and arginine vasopressin,
showing the differing amino acids at the third and eighth positions. Full chemical
structures of these peptides are given in Figures A-1 and A-2 of the appendix.
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There has been high interest in the neuropeptides OT and AVP in ASD because
of their role in social and affiliative behavior in animals.13,14 Extensive research
has been conducted and animal studies have shown that both OT and AVP
influenced deficits in social and communicative behaviors. For example, Winslow
et al. demonstrated how the administration of OT and AVP in infant mice reduced
distress calls.14 OT has been shown to reduce natural avoidance of proximity and
inhibit defensive behavior and AVP has been linked to social behaviors such as
aggression, scent marking and courtship.11,15 Though studies have shown the
implications of OT and AVP in ASD, there is a critical need to better elucidate the
neuroendocrine mechanisms of ASD.
Dynorphins. Dynorphins are a class of opioid peptides produced and secreted by
magnocellular oxytocin and vasopressin neurons.16 This class of opioid peptides
includes dynorphin A, dynorphin B, and α/β-neo-endorphin, and arises from the
precursor protein prodynorphin when it is cleaved by proprotein convertase 2
(PC2).17 Dynorphins are found widely distributed throughout the central nervous
system, but have the highest concentrations in the hypothalamus, medulla,
pons, midbrain, and spinal cord.18 They work at kappa opioid receptors and have
been linked to anxiety like behavior and negative emotional states.19,20 They are
also present in the same magnocellular nuclei responsible for synthesis of OT an
AVP and have been shown to inhibit OT and AVP secretion.21,22 While most
knowledge in regards to the ability of OT and AVP to regulate social interactions
is based on data from animal models, preliminary studies suggests that similar
social and stress related effects are present in humans.7,23 The importance of OT
and AVP in stress and in social interactions has been established, suggesting
that dysregulation of both may be associated with disorders and psychosocial
relevance like ASD. To better understand the regulatory relationships of OT,
AVP, and dynorphin new analytical tools are needed for modeling secretion and
measuring biologically relevant concentrations in ex vivo models.

1.2 Microfluidics for Brain Slice Culturing
The culturing of organotypic brain slices can preserve brain structure and
maintain the functionality of neurons within the sliced region while allowing
control of the extracellular environment.24,25 These ex vivo models are
established tools to study basal and diseases state neurochemistry.26
Conventional chambers used to culture organotypic brain slices, include interface
chambers, which supply a high concentration of oxygen directly to the slice from
above, and submerged chambers, where slices are surrounded completely by
hyper oxygenated artificial cerebrospinal fluid (aCSF). However, these chambers
do not maintain effective nutrient/waste turnover or uniform oxygen
exchange.25,27 Viability of the brain slice is dependent on the diffusion of oxygen
into the slice which is limited by the thickness of the tissue.25 The flow of oxygen
and nutrients around the slice is optimal for delivery but is limited by a thickness
of approximately 400 μm.25 Microfluidic devices have shown the potential for
3

enhanced brain slice viability by improving oxygen and nutrient penetration into
slices.25 Hill et al. demonstrates how the efficiency of the nutrient and oxygen
exchange is improved by actively flowing aCSF around the tissue.27 This causes
aCSF to be “pushed” or “pulled” through the slice, increasing oxygen availability,
thereby improving viability.27

1.3 Electrophoresis
Electrophoresis is the movement of charged molecules through a conductive
aqueous medium under the influence of an electric field generated by
electrodes.28 Sample is introduced at the anode and flows toward the cathode,
while molecules within the sample have different migration times depending on
the size of ions and magnitude of charge. Cations migrate towards the negatively
charged electrode while anions migrate towards the positively charged electrode
with the rate of ion migration depending on the charge-to-size ratio. Ions with
higher charge will migrate faster than ions with a lower charge that are the same
size and smaller ions will migrate faster than larger ions with the same charge.
Neutral molecules are not affected by the electric field.
The bulk flow of buffer solution under the influence of the electric field is known
as electroosmotic flow (EOF).28 The phenomenon is due to the formation of an
electric double layer on the inner surface of the separation channel. For example,
in capillary electrophoresis, the wall of the capillary has an excess charge due to
ionization or the adsorption of ionic species at the surface. A capillary wall coated
with fused silica has a surface made of silanol groups. The silanol groups are
ionized to negatively charged silanolate groups that will attract cations from the
run buffer and form an inner layer of cations at the wall of the capillary, known as
the fixed layer.28 All the negative charges on the capillary surface are fully
neutralized by the formation of a mobile layer of cations, that is not tightly held
because it is further away from the silanolate groups. Due to the presence of
both the fixed and mobile layers, a diffuse double layer of cations forms. The
cations present in the diffuse layer carry the bulk of the buffer solution with them
in the presence of an electric field, leading to the formation of EOF.
The electrical imbalance that is generated between the fixed and mobile layers is
known as the zeta potential (𝜉).29 The EOF is proportional to the zeta potential
and the velocity of the EOF is given by (Eq. 1):
𝑉!"# =

𝜀𝜁𝐸
4𝜋𝜂

(1)

where E is the applied electric field, 𝜀 is the dielectric constant, and 𝜂 is the
viscosity of the buffer.29 Unlike the velocity of the EOF, the electroosmotic
mobility is independent of the applied electric field and only depends on the
characteristics of the buffer.28 The electroosmotic mobility is given by (Eq. 2):
4

𝜇!"# =

𝜀𝜁
4𝜋𝜂

(2)

1.4 COMSOL Multiphysics
COMSOL Multiphysics is a cross-platform finite element analysis (FEA) solver
and Multiphysics simulation software. FEA is a numerical method used to solve
problems of engineering and mathematical models, expressed as partial
differential equations, using an array of mathematical techniques.30 It allows a
representative model of a real-life object to be developed and that model can be
used to make observations about what that object would do when met with a
specific boundary condition. A problem is split into smaller, simpler parts; a finite
number of elements. Equations that model these finite elements are solved and
assembled back into the larger system of equations that model the entire
problem.31
FEA is governed by the principle of minimization of energy.30 When certain
boundary conditions are applied to a model there are several configurations but
only one configuration is realistically possible. Due to the principle of
minimization of energy, the only configuration realistically possible is one where
the total energy is minimum.
Designed for real-world applications, the COMSOL Multiphysics simulation
environment is used to mimic effects that can be observed in the real world. In
order to set up and run a simulation, users follow a general modeling workflow
regardless of the physics being used or problem being solved. This workflow
consists of seven steps: setting up the model environment, building the
geometry, specifying material properties, defining physics boundary conditions,
creating the mesh, running the simulation, and postprocessing the results.
When first opening the COMSOL application on the desktop, the software will
prompt the user to set up the model environment by choosing between the model
wizard or a blank model. The model wizard is a guided approach recommended
for all users, regardless of experience and background. Next the user is
prompted to select the dimensional space of the model as well as the physics
interfaces that will used. A wide variety of physics interfaces such as acoustics,
electrochemistry, heat transfer, fluid flow, and more are available to simulate.
Commonly known Multiphysics, such as joule heating, are automatically precoupled with all the appropriate physics when selected but multiple physics can
be coupled as needed by the user manually. To complete the setup of the model
environment, the user is prompted to select the type of study to apply to the
model. The selected study will determine the solvers used to compute the model.
5

Users can choose from the general studies to determine whether the model will
be time dependent or stationary or preset studies for the previous selected
physics interfaces can be used.
The next step of the workflow is building the geometry. There are many drawing
tools and operations built into the COMSOL software that can be used to create
needed geometries. It is also possible to import geometries from external files or
sync geometries from design software like AutoCAD through the purchase of
add-on products. Once the model geometry is built the materials of the model
and their properties can be specified. There are several built in materials
provided by the software that can be selected. It is possible to design a model
made of various materials by adding specified materials to separate components
that compose the model. Depending on the materials and physics selected there
may be material properties that need to be defined by the user in order to
compute the problem. Material properties tied to physics are indicated by the
software.
Once the geometry is built and the material proprieties have been specified, the
next step is to define the physics. Mathematical equations can be assigned to the
model or parts of the model in order to simulate the physics. This is done by
selecting different parts of the geometry and the specifying appropriate equations
and physical conditions that describe that part. The equations representative of
any of the physical conditions used within COMSOL Multiphysics can be seen by
the user and boundary conditions and constraints can be added and changed
from the default values as needed.
When all of the boundary conditions and constraints have been defined for the
model, the next step is to create a mesh. Users have the choice between a
custom mesh, where physics of the model can be removed and not taken into
account when the mesh is generated, or the automatically generated mesh,
which is adapted to the physics settings within the model. User can choose from
shapes, such as triangles, quadrilaterals, tetrahedrons, hexahedrons, pyramids
and prisms when manually generating a mesh. Size choices also range from
extremely fine to extremely course, making a mesh completely customizable.
The next step in the workflow is to run the simulation. The software will
automatically generate plots based on the physics selected in the model. The full
Multiphysics problem being computed can be reviewed and edited by the user in
the study before the model is computed. Once the model is computed the results
can be postprocessed. Immediately after solving, a default plot appears. Existing
plots can be modified, or new ones can be created. For example, a plot showing
temperature could be easily changed to display voltage or a completely arbitrary
expression could be used so the sine of temperature multiplied by three could be
shown.
6

CHAPTER 2. MICROFLUIDIC BUBBLE PERFUSION DEVICE
2.1 Introduction
Microfluidic devices have been shown to improve the efficiency of brain slice
culturing by improving oxygen and nutrient delivery to tissues. However, the
continuous flow of aCSF used in these types of devices does not allow for timeresolved measurements of tissue secretions that contain biological molecules of
interest due to the diffusional mixing of analytes between the time of secretion
and collection of the perfusate samples. Correlating neuropeptide secretion
changes in the brain with behavior requires high temporal resolution on the
seconds timescale. The generation of monodispersed aCSF droplets ensures
that the brain slice spends equal amounts of time in media and oxygen thereby
improving the exchange. Individual droplets also allow for time resolved sampling
by providing information about the brain tissue through the molecules secreted
and collected within a droplet during a certain point in time. By keeping the
droplets separated, even when they are analyzed downstream, a high-resolution
secretion profile is obtained.
Our lab has begun the development of a microfluidic perfusion device designed
to enable time-resolved measurements of secreted factors while maintaining high
efficiency tissue oxygenation. My colleague, Amirus Saleheen, has developed
the microfluidic perfusion device, seen in Figure 2-1, that provides continuous
droplets of aCSF segmented with carbogen gas to a chamber containing the
brain tissue slice. As droplets enter the chamber and pass over the tissue slice,
biological molecules are secreted and carried away with the droplet to be
collected and analyzed further downstream. Droplets of aCSF are segmented
with carbogen gas by the use of a microfluidic T-junction. In what is known as the
squeezing regime, an emerging bubble fills most of the channel and a carrier
liquid pushes the dispersed phase forward until it cuts off. Garstecki et al.
investigated the formation of segmented droplets via the squeezing regime and
showed the size of droplets or bubbles is determined by the ratio of the
volumetric flow rates of the two immiscible fluids (Eq. 3):
𝑄$'()
𝐿$
=∝% +∝&
𝑊
𝑄*+,-

(3)

where 𝐿$ is the length of the dispersed segments, W is the width of the side
channel, 𝑄$'() and 𝑄*+,- are the volumetric flow rates of the dispersed and
continuous phase, respectively, and are constants that depend on the geometry
of the T-junction.32 The monodispersed droplets and bubbles produced ensures
the brain tissue slice spends an equal amount of time exposed to aCSF and
carbogen gas, maximizing oxygen and nutrient exchange, while also allowing for
time resolved measurements of perfusate droplets containing cellular secretions.
7

To prevent the carryover between droplets that was periodically observed when
part of a droplet broke off and was left behind in the chamber, droplet volumes
need to be greater than 50% of the chamber volume and surfaces within the
chamber need to be hydrophilic.

outlet/fraction collection
reagent delivery
tissue perfusion chamber

carbogen
gas inlet

media inlet
bubble generation

Figure 2-1. Original microfluidic perfusion device. Original device with T-junction
demonstrating squeezing regime showing a droplet’s a) filling of the junction b)
expansion into the channel and c) scission.

8

2.2 Materials & methods
2.2.1 Materials and reagents
Agarose, fluorescein disodium salt, sodium chloride, potassium chloride,
disodium phosphate, monopotassium phosphate, Sylgard® 184 silicone
elastomer base and curing agent, and acetone were purchased from Thermo
Fisher Scientific (Waltham, MA). GelBond® film was purchased from Lonza
(Morristown, NJ). A miniature pneumatic solenoid valve (model no. 20) was
purchased from Parker Hannifin Corporation (Cleveland, OH). All 3D printing was
done with the Anycubic Photon S LCD-based SLA 3D printer from Anycubic 3D
printing (Commerce, CA). LabVIEW (National Instruments, Austin, TX) was used
to automate the system. ImageJ (National Institutes of Health, Bethesda, MD)
was used for image analysis.
2.2.2 Droplet Generation
Method 1.0. Continuous flow of aCSF droplets segmented with carbogen gas
improves oxygen and nutrient exchange into brain tissue slices while also
allowing for time resolved measurement of perfusate droplets. However,
perfusion volumes are dependent on flow rates of these droplets. The volume of
a droplet is dependent on its length and width, both dimensions which are directly
proportional to the ratio of flowrates of carbogen gas and aCSF in the squeezing
regime used to produce these droplets. Reducing the volume of perfusate
droplets would decrease the dilution of secreted biological molecules. The Tjunction used in the previously developed microfluidic device was replaced by a
single inlet connected to a miniature pneumatic solenoid valve. A waveform
generator was used to supply 5V square wave pulse in order to power the valve
and a n-channel metal-oxide-semiconductor field-effect transistor (MOSFET) was
used in a circuit constructed to control the valve. Unlike like the squeezing
regime used previously, the duty cycle of the square wave signal was easily
manipulated to change the size of the bubbles and droplets. By using a duty
cycle of 50% and making the flowrates of the gas and buffer equivalent, droplets
and bubbles of equal volume were produced as seen in Figure 2-2. The pressure
of the gas was set using the regulator valve on the tank then using the tubing
dimensions, the flowrate of the gas was determined by the Hagen-Poiseuille
equation (Eq.4):
8𝜇𝐿𝑄
(4)
∆𝑝 =
.
𝜋𝑟
Where ∆𝑝 is the pressure loss, 𝜇 is the dynamic viscosity, L is the length of the
tubing, Q is the volumetric flowrate and r is the radius of the tubing. The pressure
needed for the buffer to match the flowrate of the gas was then calculated by
plugging in the flowrate of the gas and solving for the ∆𝑝. Hydrostatic pressure
was used to create the equivalent flowrate for the buffer, allowing droplets and
bubble of equal volume to be generated.
9

A

Buffer
Gas

B

Buffer

Gas

Figure 2-2. Droplet Generation. Continuous flow of droplets and bubbles generated
using method 1.0 with varying size at a) 50% duty cycle and b) 30% duty cycle.
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Method 2.0 To reduce the volume of droplets even further, a new method to
introduce the droplet to the slice in the chamber was developed. This droplet
delivery protocol enabled control of single droplet generation, effectively
decreasing perfusion volume. Using a LabView program, a DAQ, and multiple
solenoid valves, the entry of droplets and bubbles into the chamber was
controlled, instead of continuously flowing. Using separate channels, the valve
connected to a syringe containing aCSF is opened and a droplet is pushed
through the channel to the chamber housing the tissue slice. That valve is then
closed, stopping flow and effectively holding the droplet in the chamber until flow
is started again. Next, the valve connected to the gas cylinder containing the
carbogen gas is opened and a bubble flows through the channel to the chamber,
pushing the droplet out. The valve is then closed, stopping flow and leaving the
slice in the chamber surrounded by gas. All valves are connected to a simple
switch circuit programmed to send a 5V signal for a fixed amount of time to open
and close the corresponding valve at the touch of a button. By controlling when
and how long either aCSF or carbogen is flowing through the perfusion device,
the volume of the droplet can be reduced to the minimum volume needed to fill
the chamber.

A

B

C

D

Figure 2-3. Droplet delivery. Frame by frame of a) a droplet entering the channel when
the buffer valve is open b) flow stopping and the chamber being filled when the buffer
valve is closed c) a droplet being pushed out of the chamber by a bubble when the gas
valve is open d) flow stopping and the channel being filled with gas.
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2.2.3 Device Fabrication
Chip 1.0 Holes were carefully drilled into a glass microscope slide for the inlets
and outlets of the channels. Another microscope slide was then heated to
approximately 300℃ over an open flame before the channels were etched into
the surface of the glass using a laser-cutter. Once the channels were etched into
the surface the microscope slide was transferred from the open flame to a hot
plate where the temperature was maintained at 300℃ for at least 20 minutes.
The hot microscope slide was then transferred to the oven to slowly cool down to
room temperature overnight. The cooled microscope slide and the microscope
slide with holes drilled into it were then plasma cleaned and aligned to form an
airtight seal.
Chip 1.1 A mold of the same channel design as chip 1.0 was created in AutoCAD
and 3D printed using the Anycubic Photon S 3D printer. Polydimethylsiloxane
(PDMS) was then created using Sylgard 184. A 10:1 mixture of base elastomer
to curing agent was poured into the 3D printed mold. To remove any air bubbles
from the mixture, the mold was placed in a vac and left to set overnight.
Chip 1.2 A two rectangles with the dimensions of a standard microscope slide
were laser-cut from poly(methyl methacrylate) (PMMA). Holes for inlets and
outlets were drilled into the first piece while channels were etched into the
second piece using the laser-cutter. A couple of drops acetone were added to the
surface of each PMMA then they were aligned and clamped together with large
binder clips until the acetone evaporated and a seal formed.
Chip 2.0 The same method was used as for chip 1.2, except all channels meet at
a right angle, to reduce mixing of buffer and stimulant, rather than an angle less
than 90° as seen in previous chips. The channel measure approximately
500µm wide and 300µm deep (Figure 2-5).
Chamber Housing. The chamber that houses the brain tissue slice was made of
a combination of VHB tape and GelBond®. Two layers of VHB tape were
combined to make the total height of the chamber approximately 3mm. The
chamber was then laser-cut into the VHB tape. The cut tape was applied directly
to the surface of the chip after aligning the inlets and outlets of the channels and
chamber. GelBond® was added to the top of the chamber, with the hydrophilic
side facing down, to close the chamber.

12

A

B

C

Figure 2-4. Fabricated microfluidic devices. a) chip 1.0 made using glass microscope
slides b) chip 1.1 made of PDMS sitting in the 3D printed mold c) chip 1.2 made of
PMMA bonded by acetone.
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flow channel

GelBond
VHB Tape
PMMA

flow channel

tissue slice

Figure 2-5. Microfluidic bubble perfusion device. Schematic of chip 2.0 with the chamber
for a brain tissue slice.

2.3 Results & discussion
2.3.1 Droplet Generation
Method 1.0 Using a single solenoid valve at a single inlet to generate droplets
and bubbles did allow for smaller volumes and proved to be superior to the
original T-junction and squeezing regime, however, the method only worked
when using phosphate-buffered saline (PBS). When using 100uM fluorescein in
PBS buffer the droplets were no longer monodispersed at smaller volumes. The
observed irregularity of the fluorescein droplets, seen in Figure 2-6, is likely due
to the size and charge of the organic dye. The droplets seemed to be “sticking” to
the walls of the tubing when leaving the valve and before entering the channel.
This suggests that the fluorescein added to the solution increased the overall
dynamic viscosity of the fluid. This increase in dynamic viscosity makes the
fluorescein droplets more resistant to the pressure used to drive flow from the
solenoid valve through the tubing. The pressure is great enough to readily
overcome this resistance at the tubing’s axis more so than at the walls so
droplets “stick” as these forces compete, until there is enough buildup of
pressure to push the fluid some distance. The flowrate of the liquid versus the
gas could have been calculated with this new dynamic viscosity and the setup
could have been adjusted account for this but this method was not pursued
further due to the initial inability to produce monodispersed droplets. Even if the
14

flowrates were corrected and the monodispersed droplets achieved with just PBS
were duplicated, a new method was developed that reduced droplet volume even
further. This new approach was ideal because future experiments would involve
fluorescein and other organic molecules in order to image the system and verify
slice viability in the chamber. Eliminating the use of a single solenoid valve
reduced droplet volumes even further, while simultaneously improving tissue
analysis.

Figure 2-6. Fluorescein droplets. Small volume droplet of 100uM fluorescein in PBS
buffer produced by Method 1.0 that are not uniform in size and spacing.
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Method 2.0 The whole system was automated using LabVIEW and continuous
flowing droplets were replace by single droplets delivered at a specified time.
This method reduced the overall droplet volume because the minimum droplet
volume needed is dependent on the chamber volume. Previous work showed
that droplet volumes need to be greater than half the chamber volume and the
chamber surface should be mostly hydrophilic to prevent droplets from breaking
up in the chamber and being overtaken by the next droplet. A comparison of
chamber shape, size and surface can be made to optimize the tissue slice
housing. Square, diamond, and oval chamber shapes were designed in three
varying sizes that would each be able to house a suprachiasmatic nucleus
(SCN), hypothalamic, or whole mice brain slice. The contact angles of a water
droplet on the surface of various materials were also measured. The
effectiveness of any combination of all of these factors could be test by passing a
single fluorescent droplet through the chamber, followed by droplets of buffer.
The fluorescence intensity of the buffer droplets could be measured to quantify
how much carryover is left between droplets. The ideal combination of chamber
shape size and surface tension would have the least amount of carryover or the
lowest measured fluorescence intensity.
Keeping droplets segmented by bubbles is important in obtaining temporal
information from the molecules secreted by the tissue slice. By reducing the
chamber size to the minimum volume needed to house a specific size brain
tissue slice, the volume of a single droplet can also be reduced, and the dilution
of the molecules secreted into media is limited.
2.3.2 Device Fabrication
Though the small volume channels of chip 1.0 were desirable to the overall
design of this microfluidic device, they were not functional. The back pressure
within the channels was so great that it was impossible to pump droplets into the
device even when using a syringe pump. The fabrication process was also
tedious and yielded less than 50% of viable chips. This was due to the glass
frequently cracking while cooling to room temperature from experiencing thermal
stress. While the glass was heated close to its melting point in an attempt to
reduce its amorphous nature, the cooling process still happened too quickly. The
rapid changes in temperature induced stress on the surface of the glass chips
and cause cracking along the etched channels.
The PDMS mixture used to make chip 1.1 never set properly after numerous
attempts. The polymer remained tacky and never fully solidified. This is thought
to be a result of the 3D printed mold inhibiting the PDMS from curing properly
due to compounds in the resin, such as uncured monomers and photo-initiators,
leaching from the printed parts. Strategies to overcome this limitation, such as
coating the printed devices, have been proposed by others experiencing this
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problem.33 However, this method was not pursued further because smaller
channel dimensions were possible through other fabrication methods.
While PMMA is sometimes called acrylic glass, it is a tough plastic polymer used
as a glass alternative. Unlike glass, channels could be etched into the surface of
the PMMA without heating or cracking the material because it has a much lower
melting point and does not experience the same thermal stress. Chip 1.2 and 2.0
were easily reproduced and the whole fabrication process could be completed in
less than an hour. Droplets were easily flowed through the channels and the
chips were reusable. The chamber housing could easily be placed on and
removed from the surface of the PMMA device.
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CHAPTER 3. COMSOL SIMULATIONS FOR UNDERSTANDING
LATERAL ELECTROPHORESIS
3.1 Introduction
Electrophoretic methods such as isoelectric focusing and isotachophoresis have
been used for sample enrichment in capillary electrophoresis, as well as in
microfluidic devices.34,35 Generally, in these electrophoretic preconcentration
techniques, the capillary is divided into sections by a discrepancy in a property,
like pH or conductivity of solution.34 Long sample bands can be compressed into
narrow, concentrated zones, by choosing appropriate conditions to manipulate
analyte migration times in the capillary.34
In the developed microfluidic bubble perfusion device, the size of the tissue
slices, and the dimensions required to house the slice in the chamber present a
lower limit of droplet volume on the order of 10µL. In order to increase the
concentrations of molecules of interest within perfusate droplets and improve
downstream assay of cellular secretions, sample preconcentration is needed. An
electrophoretic preconcentration method was developed to be incorporated into
the microfluidic bubble perfusion device.
The developed electrophoretic platform utilizes platinum electrodes inserted in
the sides of the channel within the microfluidic device. An electric potential is
applied to the electrodes and as the perfusate droplets flow down the channel
and through the electrodes, molecules concentrate at the electrode of opposite
charge via lateral electrophoresis. The concentrated molecules at either
electrode are separated further down the channel, reducing the overall volume.
Proof-of-concept experiments were completed using 100 μM fluorescein in PBS.
Platinum electrodes were integrated into the walls of the flow channels, and
initially electric fields of 4, 8, 24, and 40 Vcm-1 were applied. In Figure 3-2, the
buffer solution can be observed boiling in the channel due to joule heating before
any separation occurs in electric fields higher then 4 Vcm-1. Two Peltier coolers
were stacked and placed directly below the channel of the microfluidic device in
order to combat the effects of joule heating. The experiments were repeated and
electric fields from 30 to 50 Vcm-1 were reached with no signs of joule heating.
Fluorescence imaging was used to confirm the concentration of fluorescein to
one side of the channel by comparing the fluorescence intensity across the
channel before and in between the electrodes. Images showed fluorescein
concentrating at the negatively charged electrode. Fluorescein is a negatively
charged molecule and therefore was expected to be observed concentrating at
the positively charged electrode. It is hypothesized that the smaller anions and
cations present in the buffer migrate through the electric field and to the
electrodes at a much faster rate than the larger fluorescein molecules, causing
ion concentration polarization.
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In Figure 3-2, 100 μM fluorescein was flowed continuously through the channel of
the developed electrophoretic platform. As the electric field was increased, the
solution could be observed boiling in the channel due to joule heating. This was
corrected with Peltier coolers, used to reduce the overall temperature in the
channel while an electric field is applied. In Figure 3-3, droplets are seen flowing
through the channel with and without the Peltier coolers. Without the
thermoelectric cooling devices, most the solution is boiled of before exiting the
channel, whereas, with the devices, no boiling is observed within the channel,
even when a higher electric field was applied.
In Figure 3-4, 100 μM fluorescein was flowed through the channel that is being
cooled by Peltier coolers. The use of the Peltier coolers keeps the channel at low
temperatures, preventing joule heating and allowing higher electric fields to be
applied. Images of the fluorescein flowing through the channel were obtained and
analyzed using ImageJ. By measuring the relative fluorescence intensity of the
channel, the accumulation of fluorescein at the electrode was confirmed. Surface
plots show high fluorescence intensity on the right side of the plot, which
corresponds to the concentration of fluorescein flowing through the channel
before reaching the electrodes. The left side of the surface plots only show
fluorescence intensity towards the top plot corresponding with the accumulation
of fluorescein on the top electrode. In all three of the electric fields shown, the
corresponding surface plots confirms the accumulation of fluorescein at the top
electrode.

PDMS

Glass

Electrode

Perfusate
Droplet

Electrode

Figure 3-1. Schematic of electrophoretic platform. Schematic with cross section of
microfluidic channel for lateral electrophoresis
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Figure 3-2. Original lateral electrophoresis experiment.100 μM fluorescein flowing
continuously through the electrophoretic channel from right to left in electric fields of a) 4
Vcm-1 b) 8 Vcm-1 c) 24 Vcm-1 d) 40 Vcm-1.
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Figure 3-3. Thermoelectric cooling. Droplets of 100 μM fluorescein in an electric field of
50 Vcm-1 a) entering the channel b) entering the electric field c) exiting the channel,
without Peltier coolers; d) entering the channel e) entering the electric field f) exiting the
channel, with Peltier coolers.
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Figure 3-4. Lateral electrophoresis with Peltier coolers. 100 μM fluorescein flowing from
right to left in a) 30 Vcm-1 b) 40 Vcm-1 c) 50 Vcm-1 electric fields with Peltier coolers to
correct joule heating. The dashed red line shows the area of the image used to make the
corresponding surface plot, confirming the migration of fluorescein to the negative (top)
electrode.
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Lateral electrophoresis was then simulated using COMSOL Multiphysics in an
effort to better understand the observed behavior of these molecules and
recreate the ion concentration polarization seen within the channel. When solving
any problem using EOF in COMSOL, electric currents or electrostatics, creeping
or laminar flow, and transport of diluted species are the three main physics
involved in the simulation. Each solves for the potential, velocity and pressure,
and concentration, respectively. The electric currents or electrostatics interfaces
are similar, both requiring an electric potential to define and electric field (Eq 5).
𝐸 = −∇𝑉

(5)

The equations in the electric currents interface are formulated with electrical
conductivity(𝜎) (Eq. 6) and using boundary conditions, the electric potential can
be specified at different locations to make electrodes with defined voltage,
current, or power applied to drive the fluid motion.
𝐽 = 𝜎𝐸

(6)

Creeping or laminar flow is determined by the Reynolds number being greater
than or less than one. The Reynolds number gives the ratio of inertial forces to
viscous forces (Eq. 7):
𝑅/ =

𝜌𝑢0 𝐿
𝜇

(7)

Where the inertial force is 𝜌, the density of the fluid, 𝑢0 , the velocity of the fluid,
and 𝐿, the width of the channel and 𝜇 is the dynamic viscosity of the fluid. When
the Reynolds number is less than one the inertial force becomes negligible
allowing the term to be ignored when solving for the Navier-Stokes equation. The
flow will be pressure-driven and solving the Eq 8. will define the parabolic flow
profile.
𝜕𝑢
J⃗
𝜌H +𝑢
J⃗ ∙ ∇𝑢
J⃗N = −∇𝑝 + 𝜇∇& 𝑢
J⃗ + 𝑓⃗
𝜕𝑡

(8)

When using electroosmotic flow the inlets and outlets are defined as having an
absolute pressure of 1 atm and the zeta potential (𝜁), electric field (𝐸- ), and
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relative permittivity (∈1 ) are used to calculate the electroosmotic velocity (𝑢(2') ) at
the walls of the channel (Eq 9.).
𝑢(2') =

−∈1 ∈0 𝜁
𝐸𝜇

(9)

The last physic, transport of dilute species, accounts for diffusion, convection
and/or migration of the species. The Nernst-Planck Equation embodies all three
modes of transport (Eq 10.):
−𝑍'#
𝐽' = −𝐷' ∇𝐶' +
𝐷 𝐶 ∇𝜙 + 𝐶' 𝑣
𝑅𝑇 ' '

(10)

Where is flux of the species, is the diffusion coefficient, is the concentration of the
species, is the potential and is the velocity of the species. The first term is
diffusion, the second term is migration and the third term is convection.
Convection is just fluid motion carrying the species and is based on the fluid flow
conditions from the creeping/laminar flow solution, so in the case of EOF the
electroosmotic velocity from the creeping flow solution is carried to the
convection term in Eq 10.

3.2 Materials & methods
3.2.1 Materials and reagents
Fluorescein disodium salt, sodium chloride, potassium chloride, disodium
phosphate, and monopotassium phosphate were purchased from Thermo Fisher
Scientific (Waltham, MA). PDMS (250µm) was purchased from Stockwell
Elastomerics (Philadelphia, PA). COMSOL Multiphysics simulations were
performed using a Dell Precision Tower 7810 Workstation. ImageJ (National
Institutes of Health, Bethesda, MD) was used for image analysis.
3.2.2 Band Dispersion in EOF
Using COMSOL Multiphysics, a model of the dispersion of a neutral species
band in EOF moving through a curved microfluidic channel was simulated.
Electric currents, creeping flow, and transport of diluted species were the three
physics used to solve this problem. The velocity field from creeping flow was
coupled to the transport properties and convection was the mechanism by which
the species moved through the channel.
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3.2.3 Simulating Electrophoresis
The simulation used to study the dispersion of a neutral species band in EOF
was used as a base model for simulating electrophoresis. The transport
mechanism was changed from convection to migration in an electric field in order
to assign a charge to species and another concentration was added. Differing
charges were assigned to the two concentrations in order to observe an
electrophoretic separation. All other physics remained the same as the original
model.
3.2.4 Simulating Lateral Electrophoresis
From there, the same physics were used to simulate the phenomenon that was
being observed in the electrophoretic channel. Properties, such as density,
concentration, and relative permittivity, of PBS were plugged in as parameters in
the simulation and an electric field of 50Vcm-1 was simulated to mimic the real-life
experiments that were already conducted. A stationary and time dependent study
was run for this simulation.

3.3 Results & discussion
3.3.1 Band Dispersion in EOF
The velocity magnitude within the curved microchannel and be observed in
Figure 3-5. It remains uniform in the straight paths of the channel but there is an
increase in velocity on the inner curve and a decrease in velocity on the outer
curve. This velocity gradient causes dispersion as the band of neutral species
travels around the curve. Molecules closer to the inside of the curve are
accelerated for a fraction of the migration time while molecules closer to the
outside are decelerated. Even though the velocity once again becomes uniform
further down the channel, after the curve, the band continues to disperse
because molecules arrive to this uniform point in the channel at different times,
as shown in Figure 3-6.
The mechanism of transport of species for this simulation was convection. The
species in this problem is neutral so it was not necessary to use migration in an
electric field as the mechanism of transport. Even though it does not use a
charged species, this simulation was used as the base model for simulating
electrophoresis because of the use of EOF.
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Figure 3-5. Velocity and electric potential. Surface plot of the velocity magnitude and
electric potential throughout the microchannel.
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Figure 3-6. Band dispersion. Neutral species band in EOF moving through a curved
microchannel at a) 0s b) 0.5s c) 1s d) 1.4s

3.3.2 Simulating Electrophoresis
In order to simulate electrophoresis, the same parameters and boundary
conditions from the previous problem were used. The mechanism of transport
was changed from convection to migration in an electric field in order to add a
charge to the species. A second species with the same concentration and a
different charge was added. The electric potential and velocity magnitude also
remained the same as previously shown in Figure 3-5.
Figure 3-7 shows two species, one with a negative charge and one with a
positive charge, moving away from each other. The electric field carries the
negatively charged species to the left while carrying the positively charge species
to the right. In Figure 3-8, the two species are moving in the same direction, to
the right, because they are both positively charged. However, the separation can
still be observed because there is a difference in migration time due to the
difference in magnitude of charge. The species with the charge of greater
magnitude travels through the channel faster, as expected.
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Figure 3-7. Electrophoretic separation 1.0. Species with -1, traveling to the left, and +1
charge, traveling to the right at a) 0s b) 27s c) 44s d) 80s.
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Figure 3-8. Electrophoretic separation 2.0. Species with +3 and +1 charge, both traveling
to the right at a) 0s b) 31s c) 60s d) 88s.
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The electrophoresis simulation happens on a larger time scale than the
dispersion of the neutral species band. This suggests that pressure driven flow is
a faster method for moving species through a microchannel. However, even
when including species of differing charges, pressure drive flow does not yield
the separation needed within the developed microfluidic device.
3.3.3 Simulating Lateral Electrophoresis
Using the same physics as the two previous simulations, the microchannel used
in proof-of-concept experiments was modeled. The flow in the channel from right
to left can be seen illustrated in the surface plot in Figure 3-9, as well as the
electric potential from the 50Vcm-1 electric field. The whole channel was not
modeled, instead just the portion right before the electrodes and slightly after the
electrodes.
When looking at the surface plot of the concentration from the stationary study, it
initially looks as if there is no concentration in the channel at all. Upon closer
inspection, zooming in on the electrode, the species can be seen concentrated
on the surface of the negative electrode. For this simulation, the mechanism of
transport is also migration in an electric field and the species observed in Figure
3-10 was given a positive charge to simulate the cations within the buffer
solution. The concentration of cations at the negative electrode in the stationary
study of this simulation support the hypothesis that the charge ions within the
buffer solution concentrate on the electrode of opposite charge, before the
fluorescein molecules travels through the electric field. The time dependent study
reflects this also, showing an increase in the concentration of cations at the
negative electrode as time elapses. The slight depletion of concentration at the
opposite electrode can also be observed. This suggest that if the charge of the
species was reversed, it would concentrate at the opposite electrode and given
two species with opposite charge, both electrodes would be an area of high
concentration within the channel.
The results of the simulation do not directly reflect what was observed in the
initial lateral electrophoresis experiments. The ion concentration polarization that
caused the fluorescein to concentrate at the electrode of the same charge is not
demonstrated in this simulation. The movement of the buffer ions to the opposing
electrodes is simulated, however, the electric field produced by these ions
concentrating in solution is not accounted for. To simulate the whole process of
ion concentration polarization, the electrostatic effects produced by the high
concentration of buffer ions at the electrodes would need to be appropriately
modeled. The transport of diluted species physics is limited in the fact that it
models diluted species that may become concentrated after transport but not the
effects after that concentration. This model could be divided into two parts where
the resulting electric field could be estimated, since it is known that it is strong
enough to cancel out the initial electric field, and used to model the effects after
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the buffer ions have concentrated but the accuracy of this second step could not
be confirmed and would not be useful for predicting the behavior of other
molecules besides fluorescein.

Figure 3-9. Flow profile and electric potential. Surface plots showing the velocity
magnitude with flow profile and electric potential at and around the electrodes.
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Figure 3-10. Stationary study. Surface plot of concentration throughout the channel with
a closer look at the change in concentration on the right.

31

A

B

D

C

E

Figure 3-11. Time dependent study. Surface plots showing the increase and decrease in
concentration at the electrodes at a) 0s b) 30s c) 60s d) 90s e) 120s.
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CHAPTER 4. FUTURE DIRECTIONS
Studying the secretion dynamics of neuropeptides enables better understanding
of endocrine mechanisms and regulatory relationships that may be involved in
neurodevelopmental disorders like ASD. Ex vivo brain tissue slices are a useful
model for studying these mechanisms, but conventional culturing techniques are
poorly suited for imaging or chemical analysis. The culturing of organotypic brain
slices can preserve brain structure and maintain the functionality of neurons
within the sliced region while allowing control of the extracellular
environment.24,25 These ex vivo models are established tools to study basal and
diseased state neurochemistry.26
The typical microfluidic device used to culture these slices uses continuous flow
of aCSF and does not allow for time-resolved measurements of tissue secretions
that contain biological molecules of interest due to the diffusional mixing of
analytes between the time of secretion and collection of the perfusate samples.
The device developed in chapter 2, generates monodispersed droplets ensuring
the tissue slice spends equal amounts of time in media and oxygen thereby
improving the exchange while also allowing for time resolved sampling.
Further development of both devices discussed in chapter 2 and 3 will deliver
technologies that address existing shortcomings in the field of neuroendocrine
characterization and brain tissue slice culture methodologies. With better
understanding of the observe phenomenon in the developed electrophoretic
channel, the preconcentration method can be incorporated to the microfluidic
device developed in chapter 2. Successful integration will yield decreased
dilution of sampled biomolecules in perfusate droplets for optimized downstream
analysis.
Once the generation and collection and perfusate droplets has been optimized
an immunoassay can also be integrated into the microfluidic device.
Fluorescence anisotropy immunoassays have been described previously as a
means for separation-free assay of secreted peptide hormones.36 In this case, a
separation-free approach is particularly attractive because it simplifies the
integration of immunoassays with the segmented droplet flow system.
In fluorescence anisotropy a fluorescent sample is excited with linearly polarized
light, and the degree of depolarization upon fluorescence emission is quantified
to determine the relative rate of molecular rotation (Figure 4-1). In a fluorescence
anisotropy immunoassay, a fluorescently labeled analog of the analyte of interest
would be added to the sample solution along with the complementary antibody.
The analyte of interest then competes with the fluorescently labeled analog to
bind to antibody. With the increasing concentration of the analyte of interest,
there would be an increase of free fluorescently labeled analog and a decrease
33

Figure 4-1. Fluorescence anisotropy. Schematic of fluorescence anisotropy optical setup
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in labeled analog-antibody complexes as a result of binding competition. Since
the rate of rotation of the fluorescently labeled analog is much greater than that
of the labeled analog-antibody complex, the degree of free vs. bound
fluorescently labeled analog can be determined via fluorescence anisotropy.36
Integrating the anisotropy immunoassay with the perfusion microdevice
will require developing the microscope instrumentation. In this set up, excitation
light is polarized via a polarizing filter before being subjected to the sample via
conventional epifluorescence microscopy. Fluorescence emission is then
collected and passed through a polarizing beam splitter to allow perpendicular
polarized components to be detected at two separate photomultiplier tubes. The
ratio of polarized signals (r) is used to determine the fluorescence anisotropy (Eq.
11):
𝑟=

𝐼|| − 𝐼4
𝐼|| + 2𝐼4

(11)

where I|| is the intensity of fluorescence emission with identical polarization to the
excitation source and I⊥ is the intensity of fluorescence emission polarized
perpendicular to the excitation source.36
The relationship between the analyte of interest concentration and r can be

calibrated using commercially available standards in order to create standard
curves to determine the concentration of each neuropeptides or other molecules
of interest in collected perfusate droplets. The future of this project will develop
the technologies needed to measure the time-resolved secretion of these
neuropeptides at biologically relevant concentrations from ex vivo brain tissue
cultures.
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Chemical structures of key molecules involved in this work

Figure A-1. Arginine Vasopressin. Chemical structure of Arginine vasopressin with
labeled amino acids

Figure A-2. Oxytocin. Chemical structure of Oxytocin with labeled amino acids
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Figure A-3. Fluorescein. Chemical structure of fluorescein disodium salt.
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